Functional analysis of HBO1 in tumor development and inhibitor screening

Guo,Ling-Li; Yu,Su-Yang; Li,Meng

doi:10.3892/ijmm.2016.2617

Functional analysis of HBO1 in tumor development and inhibitor screening

Authors:
- Ling-Li Guo
- Su-Yang Yu
- Meng Li
View Affiliations

Affiliations: Department of Colorectal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China
Published online on: May 31, 2016 https://doi.org/10.3892/ijmm.2016.2617
Pages: 300-304

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to explore the functions of histone acetyltransferase binding to origin recognition complex (ORC) 1 (HBO1) during tumor development and to screen for HBO1 inhibitors. The chromatin immunoprecipitation sequencing (ChIP-seq) data of HBO1 in the RKO human colon cancer cell line (GSE33007) were downloaded from the Gene Expression Omnibus (GEO) database. The reads were then mapped back to a reference genome hg19. The PCR duplicate reads were removed by using SAMtools software and the shift was calculated using SPP and MaSC software. The peak calling was carried out using MACS 1.4.0 software. Furthermore, the inhibitors of HBO1 were screened out from the Specs database using Dock 6.6 software. The binding sites of HBO1 were mainly distributed in the intergenic, intronic and 3'-end regions. Further analysis revealed that a total of 9,467 target genes was identified around HBO1 binding sites in the RKO cell lines and those genes mainly participated in the cell cycle, biosynthetic process, as well as other processes. Finally, 5 inhibitors with best binding affinity in the positively charged cavity of HBO1 were screened out: i) 5-[(2-hydroxybenzylidene)amino] -2-(2‑{4‑[(2‑hydroxybenzylidene)amino]-2-sulfonatophenyl}vinyl)benzenesulfonate, ii) 3-[4-(3-bromo-4-{2-[4-(ethoxycarbonyl)anilino]-2-oxoethoxy}-5-methoxybenzylidene)‑3‑methyl‑5‑oxo -4,5-dihydro-1H-pyrazol-1-yl]benzoic acid, iii) 4-(4-{3-iodo‑5‑ methoxy‑4-[2-(2-methoxyanilino)-2-oxoethoxy]benzylidene}-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid, iv) 5-chloro-1,3-bis{[3,5,6-trihydroxy-4-(octyloxy)tetrahydro-2H-pyran-2-yl]methyl}-1,3-dihydro-2H-benzimidazol-2-one and v) 4-{[4-(tetradecylamino)-1-naphthyl]diazenyl}benzoic acid. As a whole, in this study, we identified the possible binding sites and biological functions of HBO1. The potential inhibitors of HBO1 were also screened, which prove to be helpful for the inhibition of HBO1 during tumor development.

View Figures

View References

1	Karlić R, Chung H-R, Lasserre J, Vlahoviček K and Vingron M: Histone modification levels are predictive for gene expression. Proc Natl Acad Sci USA. 107:2926–2931. 2010. View Article : Google Scholar
2	Henikoff S and Shilatifard A: Histone modification: Cause or cog? Trends Genet. 27:389–396. 2011. View Article : Google Scholar : PubMed/NCBI
3	Avvakumov N and Côté J: The MYST family of histone acetyltransferases and their intimate links to cancer. Oncogene. 26:5395–5407. 2007. View Article : Google Scholar : PubMed/NCBI
4	Georgiakaki M, Chabbert-Buffet N, Dasen B, Meduri G, Wenk S, Rajhi L, Amazit L, Chauchereau A, Burger CW, Blok LJ, et al: Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription. Mol Endocrinol. 20:2122–2140. 2006. View Article : Google Scholar : PubMed/NCBI
5	Saksouk N, Avvakumov N, Champagne KS, Hung T, Doyon Y, Cayrou C, Paquet E, Ullah M, Landry AJ, Côté V, et al: HBO1 HAT complexes target chromatin throughout gene coding regions via multiple PHD finger interactions with histone H3 tail. Mol Cell. 33:257–265. 2009. View Article : Google Scholar : PubMed/NCBI
6	Burke TW, Cook JG, Asano M and Nevins JR: Replication factors MCM2 and ORC1 interact with the histone acetyltransferase HBO1. J Biol Chem. 276:15397–15408. 2001. View Article : Google Scholar : PubMed/NCBI
7	Doyon Y, Cayrou C, Ullah M, Landry AJ, Côté V, Selleck W, Lane WS, Tan S, Yang XJ and Côté J: ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell. 21:51–64. 2006. View Article : Google Scholar : PubMed/NCBI
8	Miotto B and Struhl K: HBO1 histone acetylase is a coactivator of the replication licensing factor Cdt1. Genes Dev. 22:2633–2638. 2008. View Article : Google Scholar : PubMed/NCBI
9	Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, Naiman DQ, Jenkins NA and Copeland NG: New genes involved in cancer identified by retroviral tagging. Nat Genet. 32:166–174. 2002. View Article : Google Scholar : PubMed/NCBI
10	Iizuka M, Takahashi Y, Mizzen CA, Cook RG, Fujita M, Allis CD, Frierson HF Jr, Fukusato T and Smith MM: Histone acetyltransferase Hbo1: Catalytic activity, cellular abundance, and links to primary cancers. Gene. 436:108–114. 2009. View Article : Google Scholar : PubMed/NCBI
11	Sharma M, Zarnegar M, Li X, Lim B and Sun Z: Androgen receptor interacts with a novel MYST protein, HBO1. J Biol Chem. 275:35200–35208. 2000. View Article : Google Scholar : PubMed/NCBI
12	Contzler R, Regamey A, Favre B, Roger T, Hohl D and Huber M: Histone acetyltransferase HBO1 inhibits NF-kappaB activity by coactivator sequestration. Biochem Biophys Res Commun. 350:208–213. 2006. View Article : Google Scholar : PubMed/NCBI
13	Avvakumov N, Lalonde M-E, Saksouk N, Paquet E, Glass KC, Landry AJ, Doyon Y, Cayrou C, Robitaille GA, Richard DE, et al: Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate cell proliferation. Mol Cell Biol. 32:689–703. 2012. View Article : Google Scholar :
14	Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Marshall KA, et al: NCBI GEO: Archive for high-throughput functional genomic data. Nucleic Acids Res. 37(Database): D885–D890. 2009. View Article : Google Scholar :
15	Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H, Coelho A, et al: The UCSC Genome Browser database: Update 2011. Nucleic Acids Res. 39(Database): D876–D882. 2011. View Article : Google Scholar :
16	Langmead B, Trapnell C, Pop M and Salzberg SL: Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10:R252009. View Article : Google Scholar : PubMed/NCBI
17	Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G and Durbin R: 1000 Genome Project Data Processing Subgroup: The sequence alignment/map format and SAMtools. Bioinformatics. 25:2078–2079. 2009. View Article : Google Scholar : PubMed/NCBI
18	Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W and Liu XS: Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9:R1372008. View Article : Google Scholar : PubMed/NCBI
19	Zhu LJ, Gazin C, Lawson ND, Pagès H, Lin SM, Lapointe DS and Green MR: ChIPpeakAnno: a bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics. 11:2372010. View Article : Google Scholar : PubMed/NCBI
20	DeLano WL: The PyMOL Molecular Graphics System DeLano Scientific. San Carlos, CA, USA: 2002, http://www.pymol.org.
21	Lang PT, Brozell SR, Mukherjee S, Pettersen EF, Meng EC, Thomas V, Rizzo RC, Case DA, James TL and Kuntz ID: DOCK 6: combining techniques to model RNA-small molecule complexes. RNA. 15:1219–1230. 2009. View Article : Google Scholar : PubMed/NCBI
22	Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC and Ferrin TE: UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem. 25:1605–1612. 2004. View Article : Google Scholar : PubMed/NCBI
23	Topper LM, Campbell MS, Tugendreich S, Daum JR, Burke DJ, Hieter P and Gorbsky GJ: The dephosphorylated form of the anaphase-promoting complex protein Cdc27/Apc3 concentrates on kinetochores and chromosome arms in mitosis. Cell Cycle. 1:282–292. 2002. View Article : Google Scholar : PubMed/NCBI
24	Singh N, Wiltshire TD, Thompson JR, Mer G and Couch FJ: Molecular basis for the association of microcephalin (MCPH1) protein with the cell division cycle protein 27 (Cdc27) subunit of the anaphase-promoting complex. J Biol Chem. 287:2854–2862. 2012. View Article : Google Scholar :
25	Carcagno AL, Marazita MC, Ogara MF, Ceruti JM, Sonzogni SV, Scassa ME, Giono LE and Cánepa ET: E2F1-mediated upregulation of p19INK4d determines its periodic expression during cell cycle and regulates cellular proliferation. PLoS One. 6:e219382011. View Article : Google Scholar : PubMed/NCBI
26	Hadjihannas MV, Bernkopf DB, Brückner M and Behrens J: Cell cycle control of Wnt/β-catenin signalling by conductin/axin2 through CDC20. EMBO Rep. 13:347–354. 2012. View Article : Google Scholar : PubMed/NCBI
27	Yu H: Cdc20: A WD40 activator for a cell cycle degradation machine. Mol Cell. 27:3–16. 2007. View Article : Google Scholar : PubMed/NCBI